Harvard Watch asserts that withholding essential information from public scrutiny is not uncommon at Harvard University. Maintaining that Harvard has reversed its position from extolling the virtues of public disclosure to one of imposing secrecy, the document suggests that this about face is linked to the university's recent collaboration with the private sector biomedical industry. Describing a case in which a Medical School dean knew about illegal and unethical misconduct of a research fellow 5 months prior to public exposure, the document suggests Harvard officials routinely refuse the public direct access to information about corporate sponsored research agreements or to internal records of fraud, ethical misconduct, and wastefulness. Since Harvard has recently entered into research agreements with many chemical and pharmaceutical companies, Harvard Watch recommends public disclosure of: the conclusions of academic review committees and all other committees that investigate ethical misconduct; the texts of all collaborative research agreements with private sector biomedical companies; the extramural affiliations and commitments of Harvard faculty; the name of each company that sponsors Harvard research and the dollar amount of their sponsorship; the names of the principal investigators who benefit from the sponsorship; and a detailed explanation of the purpose of the research. (SM)